- Home
- BBCP vs AVIR Comparison
BBCP vs AVIR Comparison
Compare BBCP & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBCP
- AVIR
- Stock Information
- Founded
- BBCP 1983
- AVIR 2012
- Country
- BBCP United States
- AVIR United States
- Employees
- BBCP N/A
- AVIR N/A
- Industry
- BBCP Engineering & Construction
- AVIR Medicinal Chemicals and Botanical Products
- Sector
- BBCP Consumer Discretionary
- AVIR Health Care
- Exchange
- BBCP Nasdaq
- AVIR Nasdaq
- Market Cap
- BBCP 370.5M
- AVIR 247.5M
- IPO Year
- BBCP 2017
- AVIR 2020
- Fundamental
- Price
- BBCP $6.64
- AVIR $3.25
- Analyst Decision
- BBCP Buy
- AVIR Hold
- Analyst Count
- BBCP 4
- AVIR 1
- Target Price
- BBCP $7.67
- AVIR $6.88
- AVG Volume (30 Days)
- BBCP 87.2K
- AVIR 503.8K
- Earning Date
- BBCP 01-09-2025
- AVIR 11-07-2024
- Dividend Yield
- BBCP N/A
- AVIR N/A
- EPS Growth
- BBCP N/A
- AVIR N/A
- EPS
- BBCP 0.26
- AVIR N/A
- Revenue
- BBCP $434,594,000.00
- AVIR N/A
- Revenue This Year
- BBCP N/A
- AVIR N/A
- Revenue Next Year
- BBCP N/A
- AVIR N/A
- P/E Ratio
- BBCP $25.47
- AVIR N/A
- Revenue Growth
- BBCP N/A
- AVIR N/A
- 52 Week Low
- BBCP $5.05
- AVIR $2.75
- 52 Week High
- BBCP $8.48
- AVIR $4.60
- Technical
- Relative Strength Index (RSI)
- BBCP 49.32
- AVIR 53.42
- Support Level
- BBCP $6.39
- AVIR $3.10
- Resistance Level
- BBCP $6.88
- AVIR $3.32
- Average True Range (ATR)
- BBCP 0.26
- AVIR 0.15
- MACD
- BBCP -0.12
- AVIR 0.03
- Stochastic Oscillator
- BBCP 23.81
- AVIR 88.50
About BBCP Concrete Pumping Holdings Inc.
Concrete Pumping Holdings Inc is a provider of concrete pumping services and concrete waste management services in the fragmented United States and United Kingdom markets. Its large fleet of specialized pumping equipment and trained operators position it to deliver concrete placement solutions. The company's operating segment includes U.S. Concrete Pumping; U.K. Operations; U.S. Concrete Waste Management Services and Corporate. It generates maximum revenue from the U.S. Concrete Pumping segment. Geographically, it generates majority of the revenue from its business in United States.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).